Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001753926-25-001990
Filing Date
2025-12-29
Accepted
2025-12-29 16:15:42
Documents
1
Period of Report
2025-12-23

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1537
  Complete submission text file 0001753926-25-001990.txt   3226
Mailing Address C/O PELTHOS THERAPEUTICS INC. 4020 STIRRUP CREEK DRIVE, SUITE 110 DURHAM NC 27703
Business Address
Einhorn Andrew J. (Reporting) CIK: 0001560685 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41964 | Film No.: 251609371

Mailing Address 4020 STIRRUP CREEK DRIVE SUITE 110 DURHAM NC 27703
Business Address 4020 STIRRUP CREEK DRIVE SUITE 110 DURHAM NC 27703 919-908-2422
Pelthos Therapeutics Inc. (Issuer) CIK: 0001919246 (see all company filings)

EIN.: 863335449 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)